Cargando…
Pre-clinical animal models are poor predictors of human toxicities in phase 1 oncology clinical trials
BACKGROUND: Our objective was to determine the correlation between preclinical toxicity found in animal models (mouse, rat, dog and monkey) and clinical toxicity reported in patients participating in Phase 1 oncology clinical trials. METHODS: We obtained from two major early-Phase clinical trial cen...
Autores principales: | Atkins, Johnique T., George, Goldy C., Hess, Kenneth, Marcelo-Lewis, Kathrina L., Yuan, Ying, Borthakur, Gautam, Khozin, Sean, LoRusso, Patricia, Hong, David S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7652903/ https://www.ncbi.nlm.nih.gov/pubmed/32868897 http://dx.doi.org/10.1038/s41416-020-01033-x |
Ejemplares similares
-
Ocular toxicities associated with targeted anticancer agents: an analysis of clinical data with management suggestions
por: Fu, Chen, et al.
Publicado: (2017) -
Erratum: Ocular toxicities associated with targeted anticancer agents: an analysis of clinical data with management suggestions
por: Fu, Chen, et al.
Publicado: (2019) -
Small animal clinical oncology
Publicado: (1996) -
Clinical neurologic indices of toxicity in animals.
por: O'Donoghue, J L
Publicado: (1996) -
FGFR Inhibitors in Oncology: Insight on the Management of Toxicities in Clinical Practice
por: Kommalapati, Anuhya, et al.
Publicado: (2021)